Swainsonine, a glycosylation inhibitor, enhances both lymphocyte efficacy and tumour susceptibility in LAK and NK cytotoxicity (Q38310797)
Jump to navigation
Jump to search
scientific article published on March 1994
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Swainsonine, a glycosylation inhibitor, enhances both lymphocyte efficacy and tumour susceptibility in LAK and NK cytotoxicity |
scientific article published on March 1994 |
Statements
1 reference
Swainsonine, a glycosylation inhibitor, enhances both lymphocyte efficacy and tumour susceptibility in LAK and NK cytotoxicity (English)
1 reference
Galustian C
1 reference
Foulds S
1 reference
Dye JF
1 reference
Guillou PJ
1 reference
1 March 1994
1 reference
1 reference
27
1 reference
2
1 reference
165-172
1 reference
Identifiers
1 reference
1 reference